rs11219172
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001387025.1(GRAMD1B):c.452+18859C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0928 in 152,132 control chromosomes in the GnomAD database, including 906 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.093 ( 906 hom., cov: 33)
Consequence
GRAMD1B
NM_001387025.1 intron
NM_001387025.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.395
Publications
1 publications found
Genes affected
GRAMD1B (HGNC:29214): (GRAM domain containing 1B) Predicted to enable cholesterol binding activity; cholesterol transfer activity; and phospholipid binding activity. Predicted to be involved in cellular response to cholesterol and cholesterol homeostasis. Located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRAMD1B | NM_001387025.1 | c.452+18859C>A | intron_variant | Intron 2 of 19 | ENST00000635736.2 | NP_001373954.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAMD1B | ENST00000635736.2 | c.452+18859C>A | intron_variant | Intron 2 of 19 | 5 | NM_001387025.1 | ENSP00000490062.1 |
Frequencies
GnomAD3 genomes AF: 0.0929 AC: 14115AN: 152012Hom.: 910 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
14115
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0928 AC: 14121AN: 152132Hom.: 906 Cov.: 33 AF XY: 0.0925 AC XY: 6878AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
14121
AN:
152132
Hom.:
Cov.:
33
AF XY:
AC XY:
6878
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
7484
AN:
41478
American (AMR)
AF:
AC:
1123
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
55
AN:
3470
East Asian (EAS)
AF:
AC:
197
AN:
5178
South Asian (SAS)
AF:
AC:
271
AN:
4812
European-Finnish (FIN)
AF:
AC:
798
AN:
10578
Middle Eastern (MID)
AF:
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3923
AN:
68014
Other (OTH)
AF:
AC:
159
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
638
1276
1915
2553
3191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
160
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.